ATE468157T1 - Lipoxinanaloge als neuartige restenose-hemmer - Google Patents
Lipoxinanaloge als neuartige restenose-hemmerInfo
- Publication number
- ATE468157T1 ATE468157T1 AT08006250T AT08006250T ATE468157T1 AT E468157 T1 ATE468157 T1 AT E468157T1 AT 08006250 T AT08006250 T AT 08006250T AT 08006250 T AT08006250 T AT 08006250T AT E468157 T1 ATE468157 T1 AT E468157T1
- Authority
- AT
- Austria
- Prior art keywords
- lipoxine
- restenose
- analogues
- inhibitors
- novel
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 208000037803 restenosis Diseases 0.000 abstract 2
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27293101P | 2001-03-02 | 2001-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE468157T1 true ATE468157T1 (de) | 2010-06-15 |
Family
ID=42221185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08006250T ATE468157T1 (de) | 2001-03-02 | 2002-03-01 | Lipoxinanaloge als neuartige restenose-hemmer |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1949937B1 (de) |
| AT (1) | ATE468157T1 (de) |
| DE (1) | DE60236467D1 (de) |
| ES (1) | ES2344814T3 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6048897A (en) * | 1993-06-15 | 2000-04-11 | Brigham And Women's Hospital | Lipoxin compounds and their use in treating cell proliferative disorders |
| JP2002522540A (ja) | 1998-08-13 | 2002-07-23 | メルク エンド カムパニー インコーポレーテッド | インテグリン受容体拮抗薬 |
| EP1762557B1 (de) | 2000-02-16 | 2011-04-06 | The Brigham And Women's Hospital, Inc. | Aspirin-ausgelöste Lipidmediatoren |
-
2002
- 2002-03-01 AT AT08006250T patent/ATE468157T1/de not_active IP Right Cessation
- 2002-03-01 ES ES08006250T patent/ES2344814T3/es not_active Expired - Lifetime
- 2002-03-01 EP EP08006250A patent/EP1949937B1/de not_active Expired - Lifetime
- 2002-03-01 DE DE60236467T patent/DE60236467D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| HK1118744A1 (en) | 2009-02-20 |
| EP1949937B1 (de) | 2010-05-19 |
| EP1949937A1 (de) | 2008-07-30 |
| ES2344814T3 (es) | 2010-09-07 |
| DE60236467D1 (de) | 2010-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE412448T1 (de) | Lipoxin analoge als neue inhibitoren der angiogenese | |
| MY144232A (en) | 5-substituted-2-phenylamino benzamides as mek inhibitors | |
| IS6069A (is) | N-cýanómetýlamíð sem próteasalatar | |
| PL369108A1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| GB0424833D0 (en) | Method | |
| CY1108725T1 (el) | Συνδυασμος ανταγωνιστου-nmda και αναστολεων ακετυλοχολινεστερασης δια την θεραπειαν της νοσου alzheimer | |
| MXPA03010435A (es) | Derivados de oxazol acido carboxilico sustituidos para uso como activadores de proliferacion del peroximosa(ppar-alfa y gama) en el tratamiento de diabetes. | |
| PL1983000T3 (pl) | Sposób leczenia stwardnienia rozsianego przez hamowanie aktywności IL-17 | |
| DK0699439T3 (da) | Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer | |
| ATE255412T1 (de) | Verfahren zur behandlung atherosklerose oder restenose mit hilfe eines mikrotubulusstabilisators | |
| BG106407A (en) | Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof | |
| DE60236467D1 (de) | Lipoxinanaloge als neuartige Restenose-Hemmer | |
| BR0311524A (pt) | Terapia de combinação para o tratamento de esclerose lateral amiotrófica (als) com inibidor(es) de ciclooxigenase-2 (cox 2) e uma segunda droga | |
| ATE352317T1 (de) | Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen | |
| EA200501083A1 (ru) | Соединения, активные в ингибировании пролилолигопептидазы | |
| WO2001055108A3 (en) | Use of spl a2 inhibitors for the treatment of inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |